Advancements in Psoriatic Arthritis Research

This chapter provides a comprehensive review of recent findings from a conference on psoriatic arthritis, detailing the effectiveness of new treatment options like apremilast, TAC279, and bimikizumab. The discussion encompasses diagnostic advancements, patient monitoring for mental health issues, and the safety profiles of emerging therapies. Key insights from various studies highlight the shifting landscape of psoriatic arthritis treatments and the importance of personalized patient care.